Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, burping is a recognised side effect of Wegovy. Semaglutide slows the rate at which your stomach empties, and that slower transit can mean more gas, belching and a feeling of fullness that lingers longer than usual. It is not dangerous, but it can be uncomfortable — particularly in the first few weeks of treatment or after a dose step-up. These medicines are prescription-only, and a prescriber reviews your full health picture before treatment starts.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy works by mimicking GLP-1, a gut hormone that signals fullness to the brain and, crucially, tells the stomach to take its time. That slowing of gastric emptying is precisely why appetite falls, food stays with you longer, so hunger takes longer to return. The trade-off is that a stomach that empties slowly also tends to produce more gas. Air that would ordinarily be pushed through more quickly gets backed up, and burping is often the result.
This is not a sign that something has gone wrong. The NHS medicines page for semaglutide lists eructation (the medical term for belching) explicitly among the gastrointestinal side effects of the injection. The effect tends to be most pronounced in the early weeks and after each dose increase, when the change to your digestive rhythm is at its sharpest. For a fuller picture of the broader side-effect profile, the Wegovy side effects guide covers what to expect across the full treatment journey.
Burping is also sometimes accompanied by a sulphurous or unpleasant taste. This is sometimes called the "Wegovy burp" by people on treatment, and it has its own pattern, more on that on the Wegovy burp page. Unpleasant as it is, it is the same mechanism: slowed transit, more fermentation of food in the stomach, gas produced as a result.
Once you understand the mechanism, you can see why certain behaviours make things significantly worse. Eating quickly means swallowing more air with each mouthful. Large meals press against a stomach that is already slow to process what it receives. Carbonated drinks add gas directly. Chewing gum, drinking through straws and talking while eating all add to swallowed air. On semaglutide, the normal buffering your gut would provide is reduced.
Practical adjustments that many people on treatment find helpful: eat smaller portions more slowly, pause between bites, avoid fizzy drinks entirely for the first few weeks, and sit upright for at least 30 minutes after eating. Peppermint tea is often suggested as a gentle digestive aid. None of these are medical instructions, they are the kind of eating adjustments most people make naturally once they see what triggers the belching for them specifically.
The nausea companion page is worth reading alongside this one, because nausea and burping often travel together on Wegovy and respond to similar meal-habit changes. Tiredness is another frequent companion, the fatigue guide explains why that happens and what tends to help.
For the vast majority of people, burping on Wegovy is an inconvenience rather than a medical concern. It eases with time. However, there are signals that warrant contacting your prescriber or GP promptly. Severe, persistent abdominal pain (particularly pain that radiates toward the back) is not burping discomfort; it can be a sign of pancreatitis, which the MHRA highlighted in its January 2026 Drug Safety Update on GLP-1 medicines. Pancreatitis is uncommon, but it is serious and requires urgent assessment.
Persistent vomiting, signs of dehydration, or symptoms that feel clearly different from the usual GI grumbling of early treatment are also reasons to seek advice. If burping is bad enough to disrupt daily life, it is worth speaking to your prescriber about whether a slower titration schedule might suit you better. Some people find going up in dose gradually over a longer period than the standard schedule makes the gastrointestinal effects more manageable. That decision sits with your prescriber, not a leaflet.
If you are thinking about starting Wegovy and want to know whether the side-effect profile fits your situation, the weight-loss treatment overview is a useful starting point before you speak to a clinician.
For most people, yes. The pattern reported consistently in clinical practice and in trial data is that GI side effects, including burping, are most prominent in the first four to eight weeks of treatment and after each upward dose step. As the body acclimates to the slower gastric-emptying rhythm, the symptoms tend to settle. A minority of people find they persist for longer, particularly at higher maintenance doses.
It is worth noting that the question of excessive belching specifically (rather than occasional burping) is a slightly different conversation. If belching is very frequent or very disruptive, that is worth flagging to your clinical team rather than waiting it out. Similarly, if you are on oral semaglutide rather than the injection, the semaglutide burping page covers how the GI picture compares between the two formulations.
One thing worth planning for if you order mid-month: if your pen arrives around a dose-increase point and you are ordering over a bank holiday or heading away, make sure you are not due a step-up on a week when you will have limited access to support, it is worth a quick note to your clinical team first. If you are exploring private treatment options, the guide to sourcing Wegovy safely explains what legitimate UK supply looks like.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.